Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Jonathan Rosenberg

MD
Memorial Sloan Kettering Cancer Center

Academic History

Jonathan Rosenberg, MD, is Doctor of Medical Oncology, the Chief of the Genitourinary Oncology Service and the Enno W. Ercklentz Jr. Chair at Memorial Sloan Cancer Center, New York, NY.

Dr Rosenberg received his undergraduate degree from Duke University, Durham, NC, completed his MD at Harvard Medical School in Boston, MA, his residency at New York Presbyterian/Weill Cornell Medical Center in New York and his fellowship in Medical Oncology at the University of California San Francisco Medical Center, San Francisco, CA.

Speaking on bladder, ureter, and urachal cancer

Dr Rosenberg’s research focuses on understanding the underlying bladder cancer biology with the objective of developing new therapies to treat bladder cancer. He aims to identify novel genetic biomarkers and connecting these to clinical outcomes in bladder cancer. Dr Rosenberg has previously investigated the use of enfortumab vedotin as a therapy for urothelial cancer.

Jonathan Rosenberg

Filter Results ▼
Loading... Loading results...

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.